Cosmos Health Inc. (COSM) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
COSM Revenue Growth
Revenue Breakdown (FY 2024)
COSM's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
COSM Revenue Analysis (2013–2024)
As of May 8, 2026, Cosmos Health Inc. (COSM) generated trailing twelve-month (TTM) revenue of $59.8 million, reflecting explosive growth of +37.9% year-over-year. The most recent quarter (Q3 2025) recorded $17.1 million in revenue, up 16.0% sequentially.
Looking at the longer-term picture, COSM's 5-year compound annual growth rate (CAGR) stands at +6.5%, indicating steady revenue expansion. The company achieved its highest annual revenue of $56.2 million in 2021.
Revenue diversification analysis shows COSM's business is primarily driven by Pharma manufacturing (100%). With over half of revenue concentrated in Pharma manufacturing, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HROW (+36.4% YoY), NTRB (-4.8% YoY), and XTLB, COSM has outperformed the peer group in terms of revenue growth. Compare COSM vs HROW →
COSM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| COSMCurrent | $60M | +37.9% | +6.5% | -28.6% | |
 HROW | $272M | +36.4% | +41.0% | 11.2% | |
 NTRB | $2M | -4.8% | +16.6% | -408.4% | |
 XTLB | $451,000 | - | - | -481.6% | |
 CODA | $27M | +33.2% | +5.8% | 17.1% |
COSM Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $54.4M | +2.0% | $4.3M | 7.9% | $-15,544,830 | -28.6% |
| 2023 | $53.4M | +6.0% | $4.3M | 8.1% | $-21,831,217 | -40.9% |
| 2022 | $50.3M | -10.5% | $6.0M | 11.8% | $-7,474,036 | -14.8% |
| 2021 | $56.2M | +1.5% | $8.3M | 14.8% | $-4,533,404 | -8.1% |
| 2020 | $55.4M | +39.6% | $8.1M | 14.5% | $2.7M | 4.9% |
| 2019 | $39.7M | +7.0% | $3.7M | 9.2% | $-255,809 | -0.6% |
| 2018 | $37.1M | +23.6% | $2.4M | 6.5% | $-1,228,422 | -3.3% |
| 2017 | $30.0M | +344.3% | $2.0M | 6.5% | $-4,872,321 | -16.2% |
| 2016 | $6.8M | +1165.5% | $601K | 8.9% | $-202,507 | -3.0% |
| 2015 | $534K | -93.0% | $49K | 9.2% | $-442,459 | -82.9% |
See COSM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COSM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COSM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOSM — Frequently Asked Questions
Quick answers to the most common questions about buying COSM stock.
Is COSM's revenue growth accelerating or slowing?
COSM revenue is accelerating at +37.9% year-over-year, exceeding the 5-year CAGR of +6.5%. TTM revenue reached $60M. Growth momentum has increased versus prior periods.
What is COSM's long-term revenue growth rate?
Cosmos Health Inc.'s 5-year revenue CAGR of +6.5% reflects the sustained expansion pattern. Current YoY growth of +37.9% is above this long-term average.
How is COSM's revenue distributed by segment?
COSM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.